ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

FENC vs ZURA // FREE CASH FLOW YIELD

Fennec Pharmaceuticals Inc. (NASDAQ) VS. Zura Bio Limited (Class A) (NASDAQ) • 15-METRIC TALLY: FENC 3 — ZURA 1
▲ FREE CASH FLOW YIELD LEADER: FENC
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FENC VS. ZURA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC FENC ZURA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -25.90% -35.00% +9.10 FENC /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE -3.25% -17.51% +14.26 FENC /fcf-yield <GO>
Operating Margin -14.10% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) -6.10% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 3.31 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 2/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 45.5 48.1 -2.60 ZURA /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $383.6M $370.9M $12.8M FENC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR FENC REV ZURA REV FENC GROSS % ZURA GROSS % FENC FCF ZURA FCF
FY 2025 $44.6M $0 — — -$12.5M -$64.9M
FY 2024 $47.5M $0 — — $27.0M -$28.2M
FY 2023 $21.3M $0 — — -$17.1M -$15.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FENC // BETA —
ZURA // BETA —